×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Pr Jérôme Alexandre & Dr Enora Laas


Cas clinique :  

18:30
Mise en pratique des données de DESKTOP III :

 - Recommandations de surveillance à la fin du traitement initial - Pr Jérôme Alexandre

- Nouvelles stratégies chirurgicales en rechute - Dr Enora Laas
 
19:10
Espérance de vie des patientes sous iPARP : quels nouveaux enjeux en maintenance ?
Dr Manuel Rodrigues
 
19:35
Quelles possibilités de suivi des patientes sous iPARP en pratique courante ?
Mme Pascale Dielenseger
19:45
Discussion Q&A
 

 

Shooting date : 2021-06-22
Last update : 2021-06-29
1 comment
Join the Discussion
  • l D. quand pourra-t-on avoir le replay? Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, September 10th 2024 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, September 10th 2024 from 09am to 10:30am (GMT+2)
    New York : Tuesday, September 10th 2024 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, September 10th 2024 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, September 10th 2024 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, September 10th 2024 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, September 10th 2024 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 10th 2024 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, September 10th 2024 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, September 11th 2024 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, September 11th 2024 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, September 11th 2024 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, September 11th 2024 from 05am to 06:30am (GMT+2)

    iPARP et cancer de l’ovaire : quand et pour qui ?

    Share
    Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, November 15th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, November 15th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, November 15th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, November 15th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, November 15th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, November 15th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, November 15th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, November 15th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, November 16th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, November 16th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, November 16th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, November 16th 2022 from 04am to 05:30am (GMT+1)

    Spécificités des soins de support dans le cancer de l'ovaire

    Share
    Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Monday, September 25th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Monday, September 25th 2023 from 09:30am to 11am (GMT+2)
    New York : Monday, September 25th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Monday, September 25th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Monday, September 25th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Monday, September 25th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Monday, September 25th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Monday, September 25th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Monday, September 25th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Tuesday, September 26th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Tuesday, September 26th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Tuesday, September 26th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Tuesday, September 26th 2023 from 05:30am to 07am (GMT+2)

    Les scores indispensables dans la prise en charge des cancers de l'ovaire

    Cycle d'enseignement - Les cancers gynécologiques

    Share
    Tuesday, February 6th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, February 6th 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, February 6th 2024 from 08am to 09:30am (GMT+1)
    New York : Tuesday, February 6th 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, February 6th 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, February 6th 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, February 6th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, February 6th 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, February 6th 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, February 6th 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, February 7th 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, February 7th 2024 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, February 7th 2024 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, February 7th 2024 from 04am to 05:30am (GMT+1)

    HIPEC in Ovarian Cancer - Time for change ?

    Share
    Scroll Up